[HTML][HTML] An economic assessment of contemporary kidney transplant practice

DA Axelrod, MA Schnitzler, H Xiao, W Irish… - American Journal of …, 2018 - Elsevier
Kidney transplantation is the optimal therapy for end-stage renal disease, prolonging
survival and reducing spending. Prior economic analyses of kidney transplantation, using …

A systematic review of kidney transplantation decision modelling studies

M Yaghoubi, S Cressman, L Edwards… - … Health Economics and …, 2023 - Springer
Background Genome-based precision medicine strategies promise to minimize premature
graft loss after renal transplantation, through precision approaches to immune compatibility …

Management of dyslipidemia in pediatric renal transplant recipients

ME Bock, L Wall, C Dobrec, M Chandran, J Goebel - Pediatric Nephrology, 2021 - Springer
Dyslipidemia after kidney transplantation is a common complication that has historically
been underappreciated, especially in pediatric recipients. It is also a major modifiable risk …

The lifetime health burden of delayed graft function in kidney transplant recipients in the United States

D Incerti, N Summers, TGN Ton… - MDM Policy & …, 2018 - journals.sagepub.com
Background. Although delayed graft function (DGF) is associated with an increased risk of
acute rejection and decreased graft survival, there are no estimates of the long-term or …

Monitoring tacrolimus trough concentrations during the first year after kidney transplantation: a national retrospective cohort study

SS Alghanem, MM Soliman, AA Alibrahim… - Frontiers in …, 2020 - frontiersin.org
Background: There is a lack of data in the literature on the evaluation of tacrolimus (TAC)
dosage regimen and monitoring after kidney transplantation (KT) in Kuwait. The aim of the …

Management of metabolic alterations in adult kidney transplant recipients: A joint position statement of the Italian Society of Nephrology (SIN), the Italian Society for …

C Conte, U Maggiore, G Cappelli, G Ietto, Q Lai… - Nutrition, Metabolism …, 2020 - Elsevier
Chronic metabolic alterations such as post-transplant diabetes mellitus (PTDM),
dyslipidaemias and overweight/obesity significantly impact on kidney transplant (KT) …

[HTML][HTML] 肾移植术后以他克莫司及吗替麦考酚酯为基础的激素撤除方案的研究现状

陈伯强, 张克勤 - Advances in Clinical Medicine, 2023 - hanspub.org
目的: 探索激素撤除方案对成人肾移植受者的影响, 致力于为临床决策提供参考. 方法:
充分检索近20 年国内外以他克莫司及吗替麦考酚酯为基础的激素撤除免疫抑制维持方案的临床 …

Safety and metabolic advantages of steroid withdrawal after 6 months posttransplant in de novo kidney transplantation: A 1‐year prospective cohort study

JB Bang, CK Oh, YS Kim, SH Kim… - Immunity …, 2022 - Wiley Online Library
Introduction This prospective multicenter study aimed at investigating the safety and
metabolic advantages of steroid withdrawal (SW) therapy in kidney transplant recipients with …

Individualisierung der Immunsuppression nach kardiovaskulärem Risiko–Wunsch oder Wirklichkeit?

DA Braun, B Suwelack - Nieren-und Hochdruckkrankheiten, 2021 - search.proquest.com
Nierentransplantierte Patienten haben ein deutlich erhöhtes kardiovaskuläres Risiko. Da
Nebenwirkungen der immunsuppressiven Therapie maßgeblich zu einer Verschlechterung …

[引用][C] Zur Erlangung des akademischen Grades Doktor der gesamten Heilkunde (Dr. med. univ.) an der Medizinischen Universität Wien

APPDD Manfred, LAE Burghart